These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 27452958)
1. Impact of cell culture on recombinant monoclonal antibody product heterogeneity. Liu H; Nowak C; Shao M; Ponniah G; Neill A Biotechnol Prog; 2016 Sep; 32(5):1103-1112. PubMed ID: 27452958 [TBL] [Abstract][Full Text] [Related]
2. Elucidating the effects of pH shift on IgG1 monoclonal antibody acidic charge variant levels in Chinese hamster ovary cell cultures. Xie P; Niu H; Chen X; Zhang X; Miao S; Deng X; Liu X; Tan WS; Zhou Y; Fan L Appl Microbiol Biotechnol; 2016 Dec; 100(24):10343-10353. PubMed ID: 27484582 [TBL] [Abstract][Full Text] [Related]
3. Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy. Liu H; Nowak C; Andrien B; Shao M; Ponniah G; Neill A Biotechnol Prog; 2017 Sep; 33(5):1173-1181. PubMed ID: 28547754 [TBL] [Abstract][Full Text] [Related]
4. Impact of mammalian cell culture conditions on monoclonal antibody charge heterogeneity: an accessory monitoring tool for process development. Sissolak B; Lingg N; Sommeregger W; Striedner G; Vorauer-Uhl K J Ind Microbiol Biotechnol; 2019 Aug; 46(8):1167-1178. PubMed ID: 31175523 [TBL] [Abstract][Full Text] [Related]
5. Modifications of recombinant monoclonal antibodies in vivo. Liu H; Nowak C; Patel R Biologicals; 2019 May; 59():1-5. PubMed ID: 30910309 [TBL] [Abstract][Full Text] [Related]
6. Cell culture media impact on drug product solution stability. Purdie JL; Kowle RL; Langland AL; Patel CN; Ouyang A; Olson DJ Biotechnol Prog; 2016 Jul; 32(4):998-1008. PubMed ID: 27111574 [TBL] [Abstract][Full Text] [Related]
7. Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography. Gaza-Bulseco G; Hickman K; Sinicropi-Yao S; Hurkmans K; Chumsae C; Liu H J Chromatogr A; 2009 Mar; 1216(12):2382-7. PubMed ID: 19181325 [TBL] [Abstract][Full Text] [Related]
8. Development of at-line assay to monitor charge variants of MAbs during production. St Amand MM; Ogunnaike BA; Robinson AS Biotechnol Prog; 2014; 30(1):249-55. PubMed ID: 24382831 [TBL] [Abstract][Full Text] [Related]
9. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Liu H; Bulseco GG; Sun J Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470 [TBL] [Abstract][Full Text] [Related]
10. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing. Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122 [TBL] [Abstract][Full Text] [Related]
11. Detection and consequences of recombinant protein isoforms: implications for biological potency. Federici MM; Venkat K; Bam N; Patel K; Dal Monte PR; Fernie B; Hensley P; Carr S; Baldoni J; Truneh A; Erickson J Dev Biol (Basel); 2003; 113():53-7; discussion 113-4. PubMed ID: 14620852 [TBL] [Abstract][Full Text] [Related]
12. Recombinant antibody color resulting from advanced glycation end product modifications. Butko M; Pallat H; Cordoba A; Yu XC Anal Chem; 2014 Oct; 86(19):9816-23. PubMed ID: 25181536 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab. Nebija D; Kopelent-Frank H; Urban E; Noe CR; Lachmann B J Pharm Biomed Anal; 2011 Dec; 56(4):684-91. PubMed ID: 21813259 [TBL] [Abstract][Full Text] [Related]